Global Cell Saver Market Growth 2025-2031

The global Cell Saver market size is predicted to grow from US$ 271 million in 2025 to US$ 335 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. A blood salvage machine, also known as an autologous transfusion salvage system or an autologous blood transfusion machine, is a medical device used to salvage and process a patient"s own blood during surgery before returning it to the patient. Such a system could be used to reduce the need for exogenous blood transfusions during surgery, thereby reducing the risks and complications associated with blood transfusions for patients. The blood salvage machine works by collecting the blood produced in the patient"s body through a specialized system, processing it to remove impurities and platelet aggregation, and then returning the processed blood to the patient. This method is actually a form of autologous blood transfusion, because the blood returned comes from the patient itself, and there is no compatibility problem between the donor and the recipient.

LP Information, Inc. (LPI) ' newest research report, the “Cell Saver Industry Forecast” looks at past sales and reviews total world Cell Saver sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Saver sales for 2025 through 2031. With Cell Saver sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Saver industry.

This Insight Report provides a comprehensive analysis of the global Cell Saver landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Saver portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Saver market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Saver and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Saver.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Saver market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Dual-Mode Autotransfusion Systems

Segmentation by Application:
Cardiac Surgeries
Orthopedic Surgeries
Organ Transplantation
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Haemonetics
Medtronic
LivaNova
BD
Fresenius Kabi
Beijing ZKSK Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cell Saver market?

What factors are driving Cell Saver market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cell Saver market opportunities vary by end market size?

How does Cell Saver break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.